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The vertebrate intestinal epithelium is renewed continuously from stem cells at the base of the crypt in
mammals or base of the fold in ﬁsh over the life of the organism. As stem cells divide, newly formed
epithelial cells make an initial choice between a secretory or enterocyte fate. This choice has previously
been demonstrated to involve Notch signaling as well as Atonal and Her transcription factors in both
embryogenesis and adults. Here, we demonstrate that in contrast to the atoh1 in mammals, ascl1a is
responsible for formation of secretory cells in zebraﬁsh. ascl1a / embryos lack all intestinal
epithelial secretory cells and instead differentiate into enterocytes. ascl1a / embryos also fail to
induce intestinal epithelial expression of deltaD suggesting that ascl1a plays a role in initiation of Notch
signaling. Inhibition of Notch signaling increases the number of ascl1a and deltaD expressing intestinal
epithelial cells as well as the number of developing secretory cells during two speciﬁc time periods:
between 30 and 34 hpf and again between 64 and 74 hpf. Loss of enteroendocrine products results in
loss of anterograde motility in ascl1a / embryos. 5HT produced by enterochromafﬁn cells is critical
in motility and secretion within the intestine. We ﬁnd that addition of exogenous 5HT to ascl1a /
embryos at near physiological levels (measured by differential pulse voltammetry) induce anterograde
motility at similar levels to wild type velocity, distance, and frequency. Removal or doubling the
concentration of 5HT in WT embryos does not signiﬁcantly affect anterograde motility, suggesting that
the loss of additional enteroendocrine products in ascl1a / embryos also contributes to intestinal
motility. Thus, zebraﬁsh intestinal epithelial cells appear to have a common secretory progenitor from
which all subtypes form. Loss of enteroendocrine cells reveals the critical need for enteroendocrine
products in maintenance of normal intestinal motility.
& 2013 Elsevier Inc. All rights reserved.Introduction
The intestinal epithelium is a unique vertebrate tissue that
continually renews itself throughout the life of the organism.
Epithelial cells originate from stem cells at the base of the crypt in
mammals (Spence et al., 2011) or the base of the fold in zebraﬁsh
(Ng et al., 2005; Wallace et al., 2005b) and differentiate into
enterocytes, goblet, enteroendocrine, or paneth cells as they move
out of the stem cell compartment. As cells reach the tip, they
undergo apoptosis and are shed into the lumen. Due to the
constant turnover of epithelial cells, typical neural innervation
is not common; instead, axons terminate near the epithelial cells
(Gershon, 2003). In order for luminal conditions to be commu-
nicated to enteric neurons and surrounding tissue, a variety ofll rights reserved.
lace).specialized secretory cells differentiate within the epithelium and
release their products to the basal surface (Gunawardene et al.,
2011; Moran et al., 2008). These secretions alter motility and
intestinal absorption.
During mammalian intestinal epithelial development, cells in
the developing proliferative compartments at the base of the villi
express Atoh1/Math1. Loss of atoh1/math1 prevents differentia-
tion of secretory cells (Yang et al., 2001). In contrast, Hes1 is
expressed along the villi, is excluded from secretory cells, and loss
of hes1 results in increased secretory cell differentiation (Jensen
et al., 2000). Notch signaling components are expressed in the
embryonic intestine and loss of either atoh1/math1 or hes1 results
in misregulation of Delta ligands (Jensen et al., 2000; Yang et al.,
2001). This suggests a model of lateral inhibition in which
epithelial cells expressing atoh1/math1 differentiate into secretory
cells. Differentiating secretory cells then express Notch ligands to
induce the enterocyte fate in surrounding cells by activating the
Notch signaling pathway. Activation of the Notch receptor results
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nucleus to interact with RBP-Jk resulting in the activation of
downstream genes such as hes1, which in turn represses genes
specifying the enteroendocrine fate (Fre et al., 2011; Hartenstein
et al., 2010; Schonhoff et al., 2004).
This mechanism of choice between secretory cells and enter-
ocytes has been conserved over a wide range of species. Loss of
Notch signaling in zebraﬁsh fails to specify enterocytes and many
more secretory cells develop (Crosnier et al., 2005). In the adult
Drosophila intestine, Notch signaling is required to produce enter-
ocytes, while low Notch levels produce secretory cells (Bardin
et al., 2010; Micchelli and Perrimon, 2006; Ohlstein and Spradling,
2006, 2007).
Notch continues to play an important role in the adult intestine
where signaling is required for both maintenance of the stem cell
compartment and making the choice between the secretory or
enterocyte fate. Recent work demonstrates that stem cells expres-
sing a Leucine-rich repeat containing G protein–coupled receptor 5
(Lgr5) cluster around Paneth cells (Sato et al., 2011). Paneth cells
are required for proliferation and maintenance of the stem cell
compartment and are a source of Wnt3, Notch ligand Dll4, EGF,
and TGF-A (Sato et al., 2011). Loss of Notch signaling results in
absence of crypt proliferation and differentiation of stem cells into
goblet cells (Van Es et al., 2005). In addition, as during embryogen-
esis, atoh1/math1 is required for epithelial cells to enter the
secretory fate (Van Es et al., 2010). Notch signaling is induced in
cells entering the enterocyte fate with up regulation of hes1 and
repression of atoh1/math1.
After initial differentiation into enterocyte and secretory
lineages, there is further restriction into speciﬁc subsets of each cell
type. Neurogenin3 speciﬁes the enteroendocrine lineage (Jenny
et al., 2002), while other secretory cells differentiate into goblet or
Paneth cells. Goblet cells produce mucin to lubricate the lumen and
provide a barrier to microbial invasion. Enteroendocrine stem cells
go on to differentiate into approximately 10 different lineages
(Schonhoff et al., 2004). Subtypes of enteroendocrine cells are
dispersed throughout the epithelium (Sjolund et al., 1983) and use
G protein coupled receptors, similar to oral taste receptors, to sense
luminal contents, resulting in the stimulation of mediator release
(Iwatsuki and Uneyama, 2012; Raybould, 2010). Mediators from
enteroendocrine cells act on mucosal enteric neurons and surround-
ing tissue to alter secretory and motor activity within the intestine
(Hansen and Witte, 2008; Mawe et al., 2006; Spiller, 2011). While
enterocytes develop speciﬁc regionalization along the proximal to
distal axis, speciﬁc classes of these cells are not as well deﬁned.
One well-studied enteroendocrine lineage is enterochromafﬁn
(EC) cells, which synthesize and secrete serotonin (5HT). EC cells
act as transducers, releasing 5HT in response to stretch and
pressure (Heredia et al., 2009) as well as luminal contents (Kidd
et al., 2008), resulting in altered motility and stimulation of
mucosal secretions. In mammals, fourteen 5HT receptors have
been identiﬁed: 5HT1A, 5HT1B, 5HT1P, 5HT2A, 5HT2B, 5HT3, and
5HT4 are expressed within the digestive system (Hansen and
Witte, 2008). 5HT receptors are located on both intrinsic and
extrinsic neurons as well as surrounding tissue including smooth
muscle (Hansen, 2003; Hansen and Witte, 2008; Mawe et al.,
2006). Binding to 5HT1P, 5HT3, and 5HT4 is excitatory while
binding to 5HT1A is inhibitory (Gershon and Tack, 2007; Hansen
and Witte, 2008).
Here we investigate the role of one of the zebraﬁsh acheate-
scute like family members, ascl1a, in speciﬁcation of the intestinal
epithelial secretory lineage. ascl1a expression suggests a role in
speciﬁcation of secretory cells. We ﬁnd that ascl1a null mutants
do not develop secretory cells and the entire epithelium differ-
entiates into enterocytes. ascl1 has been shown to play a role in
avian, mammalian, and zebraﬁsh delta expression (Hans andCampos-Ortega, 2002; Mizuguchi et al., 2006; Nelson et al.,
2009). We ﬁnd that ascl1a mutants fail to initiate deltaD expres-
sion within the intestinal epithelium, suggesting that ascl1a
expressing cells activate Notch signaling in neighboring cells.
Here we investigate whether Notch signaling is active throughout
the entire period of intestinal ascl1a expression. In addition, ascl1a
mutants have a loss of anterograde motility. Replacement of 5HT
initiates motility with the same velocity, distance, and frequency
found in wild type embryos. Pharmacological removal of 5HT in
wild type embryos does not, however, result in loss of antero-
grade motility.Materials and methods
Fish Stocks
Fish maintenance and matings were performed as previously
described (Westerﬁeld, 1993). AB wild type ﬁsh were used for
most procedures (Westerﬁeld, 1993). ascl1a null mutants were
obtained from Matthias Hammerschmidt and described in
(Pogoda et al., 2006). Embryos kept for motility experiments were
treated with pronase (Roche) at the end of the ﬁrst day of
embryogenesis and washed out at the beginning of the second
day of embyrogenesis in order to remove the chorion. Embryos
were allowed to grow with pigment and E3 (5 mM NaCl, 0.17 mM
KCl, 0.33 mM CaCl2, 0.33 mMMgSO4) was exchanged each day for
optimal growth.
Immunohistochemistry
Embryos were ﬁxed in 4% formaldehyde for a period of either
2 hours or overnight. Fixed embryos were then permeabilized with
Proteinase K (Sigma) or Collagenase (Sigma) in PBS (0.(186.5 mM
NaCl; 2.68102 mM KCl; 1 mM Na2HPO4 (dibasic); 6.95 mM
NaH2PO4-H2O (monobasic)) for 20 min at room temperature. Pri-
mary antibody was added and incubated at 4 1C overnight. Embryos
were then washed and incubated with secondary antibody (1:500,
Molecular Probes-Invitrogen) for two hours. Embryos for desmin and
acetylated tubulin antibody incubation were permeabilized as pre-
viously described with phospholipase A (Sigma) (Akhtar et al., 2009).
Primary antibodies are rabbit serotonin (5HT) (1:500, Sigma), mouse
2F11 (1:1000, AbCam), rabbit anti-type IIb sodium-phosphate co-
transporter (1:100 dilution, a gift of A. Werner), rabbit anti-desmin
(1:100 dilution, Sigma), mouse anti-acetylated tubulin (1:100 dilu-
tion, Sigma), mouse anti-HuC/D (1:50 dilution, Molecular Probes),
mouse anti-ZO1 (1:100 dilution, gift of Dr. S. Tsukita and T. Obara),
rabbit anti-sodium/potassium ATPase (1:100 dilution, Developmen-
tal Studies Hybridoma Bank).
For Wheat Germ Agglutinin experiments (1:100, Vector
Laboratories) embryos were permeabilized with Collagenase and
incubated overnight in PBST (186.5 mM NaCl; 2.68102 mM
KCl; 1 mM Na2HPO4 (dibasic); 6.95 mM NaH2PO4-H2O (monoba-
sic); 0.1% Tween-20). Embryos were visualized on a Nikon TE200
inverted microscope using a Hamamatsu Orca camera with IP lab
software.
At least three independent experiments were performed for all
immunohistochemical detections.
Embryo visualization
The digestive system was visualized as described previously
(Olden et al., 2008). For immunohistochemistry, intestines were
dissected and mounted separately in Vectashield (Vector Labora-
tories). For RNA in situ hybridization, skin and yolk were removed
and visualized ventrally in glycerol. Both intestine dissection and
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ascl1a, deltaD, and 2F11 expressing cells throughout the entire
intestine for embryos exposed to DAPT and DMSO.
RNA in situ hybridization
Whole mount RNA in situ hybridization was done as previously
described (Wallace and Pack, 2003). Antisense probes were
transcribed from ascl1a (Allende and Weinberg, 1994), deltaD,
phox2b (Elworthy et al., 2005). At least three independent experi-
ments were performed for all RNA in situ hybridizations.
Protein detection
ascl1a / embryos and WT siblings were grown to 5 dpf.
Brains and intestines frommutants and WT were dissected into T-
PER Tissue Protein Extraction Reagent (Pierce) with Halt Protease
Inhibitor Cocktail and EDTA (Pierce) with double the recom-
mended concentration in order to prevent protein degradation.
Also, in order to prevent sample degradation, dissected samples
were manually disrupted in the extraction buffer every two to
three dissections. Protein gel electrophoresis and western blots
were performed and blots washed as previously described
(Hongay and Orr-Weaver, 2011) with the following changes.
Protein samples were run on Bio-Rad TGX Stain-Free precast gels
and visualized on the UV setting in the BioRad Chemidoc MP
Imaging System to estimate total protein per lane. b-mercap-
toethanol was not added for protein loading as it has been
previously reported to interfere with the anti-DeltaD antibody
(Wright et al., 2011). b-actin antibody does not detect the epitope
in non-reducing conditions and equivalent quantities of extract
from the same sample were run on a gel with b-mecaptoethanol
as an additional loading control to the Bio-Rad TGX Stain-Free
precast gels. Blocking and antibody incubations were done in NAP
blockerTM (G-Biosciences). The mouse anti-Delta D (Abcam, zdd2)
and mouse anti-b-Actin antibodies (Sigma) were used 1:10,000
and incubations were done overnight at 4 1C. For detection, the
blots were incubated overnight at 4 1C with anti-mouse biotin
(Jackson Laboratories) followed by anti-mouse streptavidin-HRP
(Vectastain Elite ABC system, Vector Laboratories). Molecular
weight markers are Precision Plus Protein Kaleidoscope Standards
(BioRad). Protein detection was achieved with femtoCHROMOTM–
HRP (G-Biosciences) and visualized using the colorimetric setting
in the BioRad Chemidoc MP Imaging System.
Spatiotemporal mapping
Motility of 5 dpf embryos was recorded at one-second inter-
vals for 10 min using a Flex camera (Research Diagnostics) on a
Lecia MZ12.5 stereomicroscope with Spot software. Recordings
were then analyzed using Volumetry software written by Grant
Hennig at the University of Nevada to create Spatiotemporal maps
(STMaps) (Hennig et al., 1999). STMaps and analysis in zebraﬁsh
have been previously described (Holmberg et al., 2007). Brieﬂy,
intestinal contractions result in a change in intestine diameter
appearing as a distortion on STMaps. A number of values such as
frequency of contraction (cycles/min), velocity (mm/s), and dis-
tance (mm) of contractions can then be determined. Velocity and
distance are determined with a best ﬁt line drawn over the
contraction. At least 10 embryos are recorded for a mean value
with standard error. One-way analysis of variance was used to
reveal signiﬁcant differences between the groups. Post-hoc tests
were performed to determine either equal or unequal variances
using the Fisher test and the appropriate T test was utilized (for
equal or unequal variances). The Bonferroni correction was thenapplied to determine the appropriate level of signiﬁcance for
multiple T tests.
DAPT treatment
Notch signaling was inhibited in vivo using N-[N-(3,5-diﬂuor-
ophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT)
(Geling et al., 2002). DAPT (Sigma) was diluted to 50 mM in embryo
media. Embryos were incubated for a particular time period and
then washed out into embryo media. For DAPT exposures begin-
ning at a speciﬁc time point until 5 dpf, the DAPT was replaced
each day. Control embryos were exposed to equivalent concentra-
tions of dimethyl sulfoxide (DMSO) (Sigma).Differential pulse voltammetry
Instrumentation
Differential pulse voltammetry experiments were performed
using a CH Instrument electrochemical analyzer potentiostat (CH
Instruments Inc.) and carried out using a conventional electro-
chemical setup with the chitosan modiﬁed CFME as the working
electrode, a Ag/AgCl/3 M NaCl (BAS MF-2052, RE-5B) as the
reference electrode, and a platinum wire as the counter electrode.
Preparation of the carbon ﬁber microelectrodes
Single carbon ﬁber microelectrodes were produced as described
previously (Ozel et al., 2011). Modiﬁcation with 1% chitosan
improves selectivity by restricting access to high concentration
substances such as ascorbic acid.
In vivo electrochemical measurements in live embryos
Five dpf embryos were placed in a pocket in agarose. Chitosan
modiﬁed microelectrodes were implanted in the distal portion of
the intestine utilizing a Narishige (MO-155) micromanipulator
under a Nikon SMZ 1000 stereomicroscope. Electrochemical
measurements were carried out in E3 medium. Differential pulse
voltammetry (DPV) was used for in vivo detection of serotonin in
the potential range: 0–0.6 V at a scan increment of 4.0 mV. The
pulse period, width and amplitude were 200 ms, 50 ms and 50 mV,
respectively. Serotonin is characterized by a well-deﬁned peak
with a maximum at 0.37 V. All differential pulse voltammograms
were analyzed after background subtraction. Background current
values were recorded in E3. 5HT detection with the implanted
microelectrode is performed on live embryos.Results
ascl1a is expressed in intestinal epithelial cells in a pattern suggesting
a role in secretory cell speciﬁcation
While ascl1a expression has been extensively characterized
during zebraﬁsh brain development, expression in the developing
intestine has not been well characterized. To determine whether
ascl1a is expressed when it might play a role in speciﬁcation of
epithelial secretory cells, we characterized expression in the devel-
oping intestine. As with detection of other genes in the digestive
system, levels of tissue permeabilization need to be adjusted in order
to detect both central nervous system and digestive expression. To
conﬁrm that these permeabilization conditions produce speciﬁc
staining, we compared anti-sense and sense probes for RNA in situ
hybridization. While these conditions generate robust staining in
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probes, sense probes incubated for the same time have no staining
in the embryo demonstrating that detection of ascl1a expression is
speciﬁc.
We ﬁnd that ascl1a is expressed in a few individual intestinal
epithelial cells at 44 hpf primarily in the proximal half of the
intestine (Fig. 1A and B). The number of epithelial cells expressing
ascl1a at 48 hpf increases and expands throughout the entire
intestine (Fig. 1C). ascl1a expression is present in intestinal
epithelial cells from proximal to distal, but the cells do not appear
to be clustered (Fig. 1D). The number of ascl1a expressing cells
increases and becomes more intense by 50 hpf (Fig. 1E and F).
Multiple ascl1a expressing cells can often be observed in single
sections by 50 hpf (Fig. 1I). At 74 hpf, ascl1a is expressed in fewer
epithelial cells (Fig. 1G and H), with single cells more often foundFig. 1. Intestinal expression of ascl1a. ascl1a is expressed in a few intestinal epithelial ce
Higher magniﬁcation (B) shows individual epithelial cells expressing ascl1a, which is
48 hpf ((C), arrow points to intestine) and higher magniﬁcation (D). This changes at 50 h
often in clusters of cells (higher magniﬁcation in (F)). In cross section at 50 hpf a single
Expression of ascl1a is still strong in the intestinal epithelium at 74 hpf ((G), arrow po
display single epithelial cells expressing ascl1a (arrow in (J)). All whole mount images (
and (G) 200 mm; (B), (D), (F), and (H) 50 mm; (I) and (J) 20 mm.in cross sections (Fig. 1J). By 82 hpf, ascl1a is no longer expressed
within the intestinal epithelium.
ascl1a expression might also be expected in enteric neural
precursors as this gene is expressed in a portion of mammalian
enteric neural precursors (Blaugrund et al., 1996; Lo et al., 1991).
Zebraﬁsh enteric precursors migrate along the lateral sides of the
intestine during the second and third day of embryogenesis
creating a chain-like migration pattern (Olden et al., 2008;
Shepherd et al., 2004). Enteric neural precursor migration creates
a distinct and reproducible pattern of cells on both sides of the
intestine. Both in whole mount and in cross section, we do not
observe expression of ascl1a at any stage in the enteric precursors
that migrate along the lateral sides of the intestine. ascl1a
expression instead appears to be contained within the intestinal
epithelium. In ascl1a null mutants there is, however, a loss oflls at 44 hpf throughout the length of the intestine ((A), arrow points to intestine).
sparse and light at this stage. The number of cells expressing ascl1a increases by
pf (E), when ascl1a is expressed more evenly throughout the intestinal epithelium,
section will often display multiple epithelial cells expressing ascl1a (arrows in (I)).
ints to intestine) but cells are often less clustered. Cross sections more frequently
(A)–(H)) are oriented anterior to left and posterior to right. Scale bars: (A), (C), (E),
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embryogenesis (see below). ascl1a could act earlier before enteric
precursors reach the intestine. Alternatively, loss of epithelial
ascl1a expression may result in a lack of signals required for
stimulation of enteric neural development.
As demonstrated previously, intestinal epithelial cells have a
high proliferation rate which drops dramatically by the beginning
of the third day. Epithelial differentiation markers appear towards
the later half of the third day (Ng et al., 2005; Wallace et al.,
2005a). As ascl1a expression in individual epithelial cells during
the second and third day of embryogenesis encompasses periods
before and during secretory cell speciﬁcation, this gene may play
a role in speciﬁcation of secretory cells.acsl1a null mutants lack all secretory cells within the intestinal
epithelium
To further deﬁne a role for ascl1a in speciﬁcation of intestinal
epithelial secretory cells, we analyzed ascl1a/ embryos. Pre-
viously, a null ascl1a mutant was identiﬁed which generates a
premature stop codon, truncating the protein at amino acid 69
before any of the basic helix-loop-helix region is translated
(Pogoda et al., 2006). ascl1a null mutants result in loss of all
endocrine cells within the adenohypophysis (Pogoda et al., 2006).Fig. 2. ascl1a / 5 dpf embryos lack intestinal epithelial secretory cells. At 5 dpf WT
embryos (B) develop an increased luminal diameter in the proximal intestine (arrow), fa
intestine appears normal. The 2F11 intestinal epithelial pan-secretory cell marker revea
(C). Within ascl1a / 5 dpf embryos, secretory cells are absent throughout the entire in
side of the proximal intestine (arrow in (D) and region enlarged in (D0)). Markers for ind
the distal intestine is shown in panels (E)–(H)). Goblet cells are distributed only through
wheat germ agglutinin but are absent from ascl1a / embryos (F). Serotonin (5HT) con
epithelium along with 5HT enteric neurons as demonstrated by anti-5HT immunohisto
there are a few remaining 5HT enteric neurons (arrowheads (H)). Scale bar representsIn mammals, the major secretory cells within the intestinal
epithelium consist of goblet, enteroendocrine, and paneth cells.
In the zebraﬁsh intestine, there is presently no evidence for the
presence of Paneth cells but there are goblet and a variety of
enteroendocrine cells (Ng et al., 2005; Njagi et al., 2010; Wallace
et al., 2005a).
ascl1a/ embryos have a distinct phenotype at 5 dpf that
includes an enlarged proximal intestine and lack of an inﬂated
swim bladder (Fig. 2B compare to WT in Fig. 2A). Embryos
displaying this phenotype were conﬁrmed to be ascl1a / using
previously described PCR primers (Pogoda et al., 2006). We
analyzed 5 dpf ascl1a/ embryos for the presence of the
general secretory cell marker 2F11 as well as goblet and enter-
ochromafﬁn cells. The 2F11 monoclonal antibody was previously
identiﬁed as a pan-secretory marker, which labels secretory cells
throughout the entire intestinal epithelium (Crosnier et al., 2005).
ascl1a / embryos show no 2F11 labeled secretory cells
throughout the entire intestine (Fig. 2D compare to WT in
Fig. 2C). Goblet cells were identiﬁed with ﬂuorescently labeled
Wheat Germ Agglutinin (WGA), which labels the mucin in the
apical portion of the cells. In wild type embryos, goblet cells are
present only in the distal intestine (Fig. 2E), but in ascl1a/
embryos there is a complete absence of goblet cells (Fig. 2F).
Immunohistochemistry using anti-serotonin (5HT) antibody
demonstrates that enterochromafﬁn cells are present only in theembryos have a narrow diameter throughout the intestinal lumen (A). ascl1a /
il to completely utilize the yolk, and fail to inﬂate the swim bladder while the distal
ls numerous secretory cells distributed throughout the length of the 5 dpf intestine
testine (D). In this preparation residual pancreatic cells are observed on the lateral
ividual subtypes of secretory cells are also absent in the intestinal epithelium (only
out the distal WT intestine (E) as demonstrated by the ﬂuorescently labeled lectin,
taining enterochromafﬁn cells are distributed only throughout the distal intestinal
chemistry (G). In ascl1a / embryos, enterochromafﬁn cells are absent; however,
100 mm.
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embryos, there is a complete lack of enterochromafﬁn cells
(Fig. 2H) but a few 5HT enteric neurons differentiate along the
length of the intestine (arrowheads in Fig. 2H).
As there are no secretory cells within the 5 dpf ascl1a /
intestinal epithelium, we veriﬁed that the cells are instead
differentiating into enterocytes. We analyzed three markers of
enterocyte maturation and differentiation; alkaline phosphatase,
sodium phosphate transporter, and ZO1. Alkaline phosphatase is a
traditional marker for enterocyte maturation and has recently
been shown to detoxify LPS, a major component of gram negative
bacterial membranes (Bates et al., 2007). ZO1 is a component of
tight junctions, which form at the apical/lateral surfaces of
enterocyte sheets. The sodium phosphate transporter moves
inorganic phosphate from the lumen to maintain homeostasis.
Each of these markers is present in intestinal epithelial cells of
ascl1a / embryos in normal distribution from proximal to
distal (Fig. 3B, D and F compare to WT in Fig. 3A, C, and E). These
results suggest that ascl1a is required for secretory cell formation
but enterocytes still differentiate when expression is lost.
ascl1a null mutants fail to initiate intestinal epithelial expression
of deltaD
Regulation of deltaD expression by ascl1a appears to be depen-
dent on a speciﬁc group of E boxes within the HII control region
(Hans and Campos-Ortega, 2002). We therefore determinedFig. 3. Intestinal enterocytes differentiate with characteristic markers in ascl1a /
 5 dpf embryos. Enterocytes differentiate within the ascl1a / intestinal
epithelium as demonstrated by apical alkaline phosphatase (blue in (B) compared
to WT in (A)), apical sodium phosphate transporter (NaPi) (green in (D) compared
to WT in (C)), and the tight junction marker ZO-1 (green in (F) compared to WT in
(E)). Apical alkaline phosphatase in ascl1a / is typically less than WT but NaPi
and ZO-1 are present at the same intensity. Scale bar represents 50 mm except in
(A) and (B) where the bar is 20 mm.whether loss of ascl1a also results in loss of deltaD expression
within the intestinal epithelium. At 74 hpf, DeltaD protein has been
found to be present in a punctate distribution within developing
secretory cells (Crosnier et al., 2005). While we observe a similar
distribution of DeltaD within the intestine, this pattern is not useful
for determining number and distribution of Delta D cells in whole
mount embryos as the protein is not present around the periphery
of the entire cell. deltaD RNA expression is an effective means to
determine the numbers of cells expressing the gene. deltaD is lightly
expressed in isolated cells throughout the proximal to distal extent
of the intestinal epithelium on the second (50 hpf; Fig. 4A and B)
and more intensely during the third day of embryogenesis (74 hpf;
Fig. 4C and D). The number and distribution of cells has similarities
to intestinal ascl1a expression but is delayed. Groups of clustered
ascl1a cells form at 50 hpf in the intestinal epithelium but are more
isolated by 74 hpf. In contrast, deltaD intestinal epithelial cells begin
as more small clusters and individual cells at 50 hpf (Fig. 4B), but
increase in number and form larger clusters at 74 hpf. This time
delay would be expected if ascl1a plays a role in initiation of deltaD
expression.
With loss of ascl1a expression in null mutants, we expect a
concomitant loss of epithelial deltaD expression. We performed
this assay at 74 hpf when intestinal epithelial expression of deltaD
expression is stronger. ascl1a / embryos do not display an
observable phenotype before 5 dpf so we analyzed deltaD expres-
sion in embryos of mixed genotype at 74 hpf from a heterozygote
cross of two ascl1a carriers (þ/). All of the embryos retain
central nervous expression in both the brain and neural tube
(Fig. 4C, E, G, and H) but a quarter of the embryos have no
intestinal expression of deltaD (Fig. 4 E and F). We conﬁrmed that
embryos lacking intestinal deltaD expression are ascl1a null by
genotyping the embryos with previously described PCR primers
(Pogoda et al., 2006).
Loss of deltaD mRNA expression in ascl1a / intestines
should also result in loss of protein expression. To determine if
ascl1a loss of function embryos lack intestinal DeltaD, we dis-
sected equivalent numbers of intestines and brains from both
mutant and wild type siblings at 5 dpf (when the phenotype
becomes visible) for western analysis. Similar to loss of deltaD
mRNA expression in ascl1a / embryos, we ﬁnd a loss of DeltaD
in the mutant intestine but not the brain (Fig. 5). In contrast, wild
type siblings have DeltaD in both intestine and brain (Fig. 5). Both
the lack of DeltaD mRNA and protein expression suggests that
ascl1a plays a role in initiating and/or maintaining intestinal
deltaD expression. ascl1a is required for secretory cell differentia-
tion. This suggests that high levels of deltaD are expressed in cells
differentiating as secretory cells which would then activate Notch
in surrounding cells to limit the number of secretory cells by
lateral inhibition.
Notch gamma-secretase inhibition changes the number of ascl1a
expressing cells
Previously, experiments have identiﬁed increases in secretory
cell formation where either Notch signaling is absent throughout
all of embryogenesis or between the ﬁrst and third dpf (Crosnier
et al., 2005; Van Es et al., 2005; Zecchin et al., 2007). While these
results indicate that Notch signaling is required for limiting the
number of intestinal epithelial secretory cells, it is unknown
whether Notch signaling is required continuously or only during
speciﬁc periods in order to accomplish this reduction. Expression
of ascl1a suggests that Notch signaling may be active during the
during the entire period of 44–82 hpf.
To determine when signaling is required, we took the
approach of inhibiting Notch signaling for speciﬁc periods during
embryogenesis. Inhibition of Notch signaling should result in an
Fig. 4. Intestinal expression of deltaD in WT and ascl1a / embryos. deltaD expression in the intestinal epithelium begins on the second day of embryogenesis by 50 hpf
((A), arrow: intestinal expression; arrowhead: neural tube expression out of focal plane) with stronger expression in the proximal intestine. Magniﬁed view of 50 hpf
deltaD expression (B) demonstrates small clusters and some isolated intestinal epithelial cells. deltaD expression becomes stronger and more even throughout the
intestinal epithelium at 74 hpf ((C): arrow; arrowhead: neural tube expression out of focal plane). Magniﬁed view of 74 hpf (D) demonstrates that deltaD is now expressed
in larger clusters and higher numbers of intestinal epithelial cells. ascl1a / embryos lack expression of deltaD within the intestinal epithelium at 74 hpf (arrow in (E))
but retain neural tube expression (arrowhead in (E) out of focal plane). Magniﬁed view of ascl1a / (F) shows absence of deltaD expression in intestinal epithelium.
Within the same ascl1a / embryos, deltaD expression in the brain is altered but remains strong (compare WT in (G) to ascl1a / in (H)). Anterior is to the left and
posterior to the right in all panels. Scale bars: (A), (C), (E), (G), and (H) 200 mm; (B), (D), and (F) 50 mm.
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secretory cells only when signaling is active. The increased
number of cells speciﬁed as secretory cells should also express
ascl1a. If Notch signaling is active throughout the entire period of
ascl1a expression, then there should be increases in the number of
ascl1a expressing cells any time Notch is inhibited between 44
and 82 hpf. Alternatively, if Notch signaling is only required for
distinct periods, then increases in ascl1a expressing cells will only
occur when signaling is inhibited for speciﬁc periods.
Notch signaling was inhibited for speciﬁc periods with the
addition of DAPT followed by washout into E3. DAPT inhibits
gamma secretase and prevents cleavage of the Notch intracellular
domain (NICD), preventing activation of Notch target genes
(Geling et al., 2002). We ﬁrst surveyed the time span between
the ﬁrst to third days of embryogenesis with DAPT inhibition for
12–14 h periods. Embryos exposed to DAPT were analyzed for
ascl1a expression at 74 hpf towards the end of acsl1a expression
in the intestinal epithelium. In this initial survey, we found that
Notch signaling only increases ascl1a expressing epithelial cells
during speciﬁc 12–18 h periods between 30–48 hpf and 60–
74 hpf. These periods with increased numbers of ascl1a expres-
sing epithelial cells were divided into four hour blocks to identify
more speciﬁc times when Notch signaling is required. Inhibitionof Notch signaling resulted in signiﬁcant increases in the number
of ascl1a only during the periods of 30–34 hpf and again during
64–74 hpf (Fig. 6A). There were no signiﬁcant increases in ascl1a
expressing cells during the other time periods (Fig. 6A), suggest-
ing that Notch signaling is only active in secretory cell speciﬁca-
tion from 30 to 34 hpf and again during 64–74 hpf.
Notch gamma-secretase inhibition increases the number of deltaD
expressing cells
If ascl1a expression plays a role in initiation of deltaD expres-
sion, then periods of Notch inhibition with DAPT with increases in
ascl1a intestinal epithelial cells should also increase numbers of
deltaD expressing cells. In the previous section, we ﬁnd increases
in ascl1a intestinal epithelial cells only when Notch is inhibited
between 30–34 hpf and 64–74 hpf. Therefore, the number of
intestinal epithelial cells expressing deltaD should also only
increase during these two periods when Notch is active.
We inhibited Notch signaling using DAPT for three periods
during 30–34 hpf, 34–48 hpf, and 64–74 hpf and assayed num-
bers of intestinal epithelial cells expressing deltaD at 74 hpf.
Similar to observed increases in ascl1a expressing cells, we ﬁnd
increases in deltaD expressing cells only when Notch is inhibited
Fig. 5. Intestinal expression of DeltaD in WT and ascl1a / embryos. (A) Both
mutant and WT 5 dpf intestines and brains were dissected for western blot. Brains
for both WT and ascl1a / demonstrate similar levels of DeltaD and the loading
control b-actin. ascl1a / intestines lack DeltaD while there are similar levels of
b-actin compared to WT. DeltaD is approximately 100 kD while b-actin is 55 kD.
(B) Total protein as visualized by induced ﬂuorescence on stain-free gel. Proteins
are visualized after electrophoresis but before transfer to membrane as an
alternative loading control to b-actin. The protein gel for DeltaD was run without
b-mecaptoethanol (BME) and shown to the left while protein gel for b-actin was
run with b-mecaptoethanol (BME) and is shown to the right. The same volume of
protein from the same sample was loaded on both the BME and no BME gels.
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This suggests that additional intestinal epithelial cells become
speciﬁed as secretory cells and initiate deltaD expression. This
lends further support to the idea that Notch signaling is only
active during discrete periods rather than continuously during
secretory cell speciﬁcation.
Notch gamma-secretase inhibition increases the number of epithelial
secretory cells by the midpoint of embryogenesis
If Notch signaling is only active during the periods of 30–34
and again between 64 and 74 hpf as suggested by increases in
ascl1a and deltaD during these periods, then Notch inhibition
should only increase the number of secretory cells during the
same periods. We used DAPT to inhibit Notch signaling for three
time periods at 30–34 hpf, 34–48 hpf, and 64–74 hpf. Inhibition
for the period of 34–48 hpf was used to demonstrate a lack of
increased numbers of secretory cells.
To identify differentiating secretory cells early in embryogen-
esis, we used the pan-secretory monoclonal antibody 2F11 at
74 hpf, which is the ﬁrst time this marker is present in the
intestinal epithelium. During this period other markers of secre-
tory cell differentiation are not yet expressed. We ﬁnd increases
in secretory cells when Notch signaling is inhibited between 30
and 34 hpf but are not statistically signiﬁcant. The p value
generated in the T test is just above the level of signiﬁcance withapplication of the Bonferroni correction (p¼0.029 with a level of
signiﬁcance po0.025). This suggests a trend of increased secre-
tory cell numbers that might become signiﬁcant with an
increased sample size. As expected, we ﬁnd no signiﬁcant
increase in the numbers of secretory cells upon Notch inhibition
from 34 to 48 hpf (Fig. 6C). Inhibition of Notch signaling between
64 and 74 hpf increases secretory cell numbers however, at 74 hpf
most of the epithelium appears to express the 2F11 epitope. Since
embryos were ﬁxed just after DAPT inhibition, we thought that
this might be affecting 2F11 expression. To allow additional time
between DAPT inhibition and ﬁxation, we again inhibited Notch
signaling with DAPT but allowed the embryos to develop until
96 hpf. At 96 hpf, we ﬁnd that 2F11 is expressed in cells with
characteristic secretory cell shape and no longer throughout the
entire epithelium. Comparison of Notch inhibition between 64
and 74 hpf and DMSO control embryos demonstrates a signiﬁcant
increase in secretory cells at 96 hpf (Fig. 6D). Therefore, upon
Notch inhibition with DAPT between 30–34 hpf and 64–74 hpf,
we ﬁnd increases in cells expressing ascl1a and deltaD as well as
increases in the overall number of intestinal epithelial secretory
cells.Notch gamma-secretase inhibition changes the ﬁnal subtype
composition of secretory cells in the 5 dpf intestinal epithelium
Embryos which underwent Notch inhibition during 30–34 and
again during 64–74 hpf were grown to 5 dpf and analyzed for
changes in secretory cell numbers. In addition to the 2F11 anti-
body, we utilized markers of differentiated secretory cells for
enterochromafﬁn and goblet cells. 5HT was used to identify
enterochromafﬁn cells while wheat germ agglutinin (WGA) was
used to identify mucin in goblet cells. Embryos exposed to DAPT
only during the 30–34 hpf or 64–74 hpf period did not have
signiﬁcant changes in the number or type of secretory cells at
5 dpf. We hypothesized that there may be a compensatory affect
within the epithelium after Notch inhibition by DAPT is relieved,
resulting in subsequent restoration of the wild type secretory to
enterocyte ratio.
To determine whether increased numbers of secretory cells
could be retained until the end of embryogenesis, Notch inhibi-
tion using DAPT was continued until 5 dpf. We began DAPT
exposure beginning around the times when we observe increases
in ascl1a, deltaD, or secretory cell numbers at 74 hpf (30–60 hpf)
or when Notch signaling appears to not be active (34 hpf). We
again used 2F11 antibody and markers of differentiated secretory
cells for enterochromafﬁn (5HT) and goblet cells (WGA).
With continuous Notch inhibition until 5 dpf, we do not ﬁnd
much change in overall numbers of secretory cells beginning at
any of the three time points as demonstrated by similar numbers
of 2F11 cell counts (Fig. 7A). Due to the large number of secretory
cells in the 5 dpf intestinal epithelium, we sampled the number of
secretory cells in both the proximal and distal intestine. Using
2F11, we recorded a representative sampling of secretory cells,
measuring 100 mm from each end of the intestine and then
counted cells for the next 200 mm. 2F11 demonstrates slight but
signiﬁcant decreases in the proximal epithelium when exposure
begins at 30–60 hpf. The distal epithelium has no signiﬁcant
increase in 2F11 cells (Fig. 7A). Individual secretory subtypes
however, do change more signiﬁcantly.
Enterochromafﬁn (EC) cells demonstrate a signiﬁcant increase
when exposure begins at 30 hpf. There is no signiﬁcant change
when exposure begins at 34 or 60 hpf (Fig. 7B). With speciﬁc
staining for goblet cells using wheat germ agglutinin, goblet cells
decrease by 42% when exposure begins at 34 hpf, but then
increases by 37.2% when exposure begins at 60 hpf (Fig. 7C).
Fig. 6. Effects of inhibition of Notch signaling within the intestinal epithelium. Embryos from three independent experiments were exposed to the gamma-secretase
inhibitor DAPT, or DMSO as a control, for 4–14 h periods followed by washout and return to embryo media. Embryos were then assayed for increases in the number of
ascl1a (A), deltaD (B) (by RNA in situ hybridization), or 2F11 (using immunohistochemistry). (C) expressing cells throughout the entire intestine at 74 hpf. For ascl1a and
deltaD RNA in situ hybridization, the yolk was removed and intestinal cells were counted. Embryos were assayed (D) for increases in secretory cells (2F11) after Notch
inhibition between 64 and 74 hpf and at 96 hpf instead of at 74 hpf. In panels A through (C), a two-way analysis of variance showed a signiﬁcant difference between time
and DAPT inhibition; (A) F(6,238)¼16.162, p¼0.00, (B) F(2,96)¼15.504, p¼0.00, (C) F(1,56)¼5.086, p¼0.028. In post-hoc tests, either equal or unequal variances were
identiﬁed using the Fisher test and the appropriate T test was utilized (equal or unequal variances). Two-tailed student T tests with unequal variances (Welch’s T test) are
used for 30–34 hpf, 34–48 hpf, and 64–68 hpf in panel (A) while the rest have equal variances. p values from the appropriate T test are indicated above the time periods
with a signiﬁcant difference when compared to DMSO control group after Bonferroni correction ((A) po0.0071; (B) po0.0167; (C) po0.025). While the p value for 30–
34 hpf in panel (C) (p¼0.029) is not signiﬁcant using the Bonferroni correction, the value is just above the level of signiﬁcance po0.025) and labeled with an asterisk to
indicate a trend of increased numbers of secretory cells. Each of the other time periods do not result in signiﬁcantly different values when compared to the DMSO controls.
Black lines on bars represent standard deviation. Total number of individuals tested from each of the three independent experiments are as follows; Panel (A) 26–30 DAPT:
n¼22, DMSO: n¼21 30–34 DAPT: n¼20, DMSO: n¼23 34–48 DAPT: n¼20, DMSO: n¼14 48–60 DAPT: n¼14, DMSO: n¼17 60–64 DAPT: n¼14, DMSO: n¼18 64–68
DAPT: n¼18, DMSO: n¼15 68–74 DAPT: n¼20, DMSO: n¼16 Panel (B) 30–34 DAPT: n¼15, DMSO: n¼18 34–48 DAPT: n¼16, DMSO: n¼17 64–74 DAPT: n¼19, DMSO:
n¼17 Panel (C) 30–34 DAPT: n¼20, DMSO: n¼11 34–48 DAPT: n¼15, DMSO: n¼14 Panel (D) 64–74 DAPT: n¼15, DMSO: n¼15.
G. Roach et al. / Developmental Biology 376 (2013) 171–186 179The increase in goblet cells with DAPT exposure beginning at
60 hpf is similar to inhibition of Notch receptor cleavage with
another gamma secretase inhibitor, DBZ. In the adult mammalian
intestine, conditional inhibition of Notch receptor cleavage trans-
forms the transit amplifying compartment of the crypt into post-
mitotic goblet cells accompanied with a complete loss of mitotic
proliferation (Van Es et al., 2005). Notch signaling during the later
half of embryogenesis may be initiating formation of the future
zebraﬁsh adult stem cell compartment in a manner similar to the
mammalian adult crypt.
Absence of intestinal secretory cells results in loss of distal intestinal
motility
In the adult intestine, motility requires the presence of func-
tional smooth muscle and an enteric neural network coupled with
interstitial cells of cajal (ICC) (Hennig et al., 2010; Huizinga et al.,
2011, 2009). As a result, we began our investigation of intestinal
motility with analysis of smooth muscle and enteric neurons in
5 dpf ascl1a / embryos. In acsl1a / embryos, using desmin
immunohistochemistry, we observe differentiated circular and
longitudinal smooth muscle with a wild type appearance in both
the proximal (Fig. 8B compared to Fig. 8A) and distal intestine
(Fig. 8D compared to Fig. 8C). However, recording the number of
enteric neurons throughout the entire intestine, we ﬁnd thatascl1a / embryos have only 9.6% of the neurons found in WT
5 dpf embryos (WT 407.7756.4; n¼10 and ascl1a /
39.4712.9; n¼9, p¼2109 from 2 tailed Welch’s student T test
for unequal variances). Even though the enteric neurons are
severely reduced, they appear to be evenly spaced throughout the
length of the entire ascl1a / intestine (proximal Fig. 8F compared
to Fig. 8E; distal Fig. 8H compared to Fig. 8G). Lower numbers of
enteric neurons in ascl1a / intestines correspond to a signiﬁ-
cantly reduced neuronal ﬁber density (proximal Fig. 8J compared to
Fig. 8I; distal Fig. 8L compared to Fig. 8K). Many of the proximal
neurites appear to be extrinsic as they arise from large neurons that
travel into the intestine through the esophagus. The paucity of
enteric neurons is not likely to form normal reﬂex circuits. How-
ever, even without normal enteric neural circuits, smooth muscle
could retain the ability to generate intestinal motility.
Loss of the majority of enteric neurons may result from a
failure of enteric neural precursors to proliferate and migrate
through the intestine. Alternatively, enteric neural precursors
may proliferate and migrate to the correct position but fail to
differentiate. To begin to distinguish between these alternatives,
we used expression of phox2B, which is expressed in enteric
neural precursors as they migrate through the intestine. We are
unable to distinguish ascl1a / embryos phenotypically at
74 hpf so we observed phox2B expression in the entire progeny
from crosses between heterozygotes. At 74 hpf, enteric neural
Fig. 7. Effects of Notch inhibition on secretory cells at the end of embryogenesis. Embryos from three independent experiments were exposed to the gamma-secretase
inhibitor DAPT, or DMSO as a control, beginning at three time points then continually until 5 dpf. Embryos were assayed for the pan-secretory cell marker 2F11 (A),
enterochromafﬁn cells (B), goblet cells (C). In panels (A) through (C), a two-way analysis of variance showed a signiﬁcant difference between time and DAPT inhibition;
(A) Proximal F(2,140)¼11.09, p¼0.00 (B) F(2,131)¼7.148, p¼0.00 (C) F(2,118)¼20.95, p¼0.00. There was no signiﬁcant interaction between time and DAPT inhibition in
distal measurements in panel (A) F(2,150)¼1647, p¼0.96. In post-hoc tests, either equal or unequal variances were identiﬁed using the Fisher test and the appropriate T
test was utilized (equal or unequal variances). Two-tailed student T test with unequal variances (Welch’s T test) are used for 30–120 hpf in panel (B) while the rest have
equal variances. P values from the appropriate T test are indicated above the time periods with a signiﬁcant difference when compared to DMSO control group. Each of the
other time periods do not result in signiﬁcantly different values when compared to the DMSO controls. Black lines on bars represent standard deviation. Total number of
individuals tested from each of the three independent experiments are as follows; Panel (A) 30–120 hpf DAPT n¼12, DMSO n¼24 34–120 hpf DAPT n¼15, DMSO n¼26
60–120 hpf DAPT n¼31, DMSO n¼29 Panel (B) 30–120 hpf DAPT n¼22, DMSO n¼25 34–120 hpf DAPT n¼12, DMSO n¼16 6–120 hpf DAPT n¼26, DMSO n¼23 Panel
(C) proximal 30–120 hpf DAPT n¼17, DMSO n¼25 34–120 hpf DAPT n¼11, DMSO n¼16 60–120 hpf DAPT n¼46, DMSO n¼43 distal 30–120 hpf DAPT n¼17, DMSO
n¼25 34–120 hpf DAPT n¼11, DMSO n¼16 60–120 hpf DAPT n¼46, DMSO n¼43.
Fig. 8. Smooth muscle and enteric neurons in ascl1a / at 4–5 dpf. Smooth muscle within the digestive system appears normal from proximal ((B) compared to (A)) to
distal ((D) compared to (C)) in ascl1a / 5 dpf embryos as determined by desmin immunohistochemistry. Neuronal cell bodies highlighted by Elav 1 are numerous in
both the proximal (E) and distal (G) WT intestine at 5 dpf but have been severely reduced in the proximal (F) and distal (H) ascl1a / intestine. Neurite density is also
severely reduced in both the proximal (J) and distal (L) ascl1a / intestine when compared to WT proximal (I) and distal (K) as shown with acetylated tubulin. Scale bars
represent 50 mm.
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have begun circumferential migration in the proximal portion
(Olden et al., 2008). We removed the yolk to visualize phox2b andFig. 9. Migration of enteric neural precursors within ascl1a / embryos. At 74 hpf ent
migrated in two lateral lines to the distal end of the digestive system (A). In genotype
lateral lines to reach the distal intestine at 74 hpf (B) similar to WT (A). At 96 hpf, phox2
longer present in the ascl1a / intestine at the same time (D). Scale bars represent 5
Fig. 10. Anterograde intestinal motility in ascl1a / 5 dpf embryos. Spatiotemporal ma
in (A), (C), and (E)). Just distal to the swim bladder there is a region that generates both
and anterograde contractions are indicated by arrows (R-retrograde and A-anterograde)
are identiﬁed by changes in opacity, which create darker bands and travel downwards
line representing the contraction (indicated by blue line), and distance is calculated by
ten minutes. The origin of retrograde and anterograde contractions are indicated at t
contractions. ascl1a  / embryos (C) with a similar region of interest (red box) genera
contractions. Upon addition of serotonin to ascl1a / embryos (E), anterograde contrac
anterograde contractions in (F)–(B)).ﬁnd no apparent differences between any of the embryos. To
conﬁrm that ascl1a / embryos are present in this group, each
of the embryos were imaged and then genotyped with previouslyeric neural precursors, as demonstrated by phox2b RNA in situ hybridization, have
d ascl1a / embryos, enteric neural precursors also migrate in similar duplicate
b is distributed around the circumference of the WT intestine (C) while they are no
0 mm.
ps (STMaps) were generated by drawing a box around the area of interest (red box
retrograde and anterograde contractions. Length and start position of retrograde
. (B) WT STMap generated from area of interest in panel (A). Individual contractions
over time (indicated at side of STMap). Velocity is calculated using the slope of the
measuring the length of the line (indicated by yellow line). Motility is recorded for
he top of the panel. Retrograde contractions are more frequent than anterograde
te an STMap (D) with only retrograde contractions and an absence of anterograde
tions (F) are restored at a similar frequency, distance, and velocity to WT (compare
Table 1
Changes in 5 dpf intestinal motility analyzed with volumetry. Motility is separated into retrograde and anterograde contractions with average differences in frequency of
contraction (cycles/min), distance (mm), and velocity (mm/s) (n¼10 for each group). WT retrograde contractions occur at almost double the frequency of anterograde
contractions, but travel about half the distance. Velocity for both retrograde and anterograde contractions are similar. While there is not much change in frequency and
distance of retrograde ascl1a / contractions, anterograde contractions are absent. Anterograde contractions are replaced by occasional movement, which appears to
involve pressure release from the enlarged proximal intestine. The entire distal intestine opening is represented by high velocity of contraction but similar distance to WT.
Anterograde contractions are restored to frequency, distance, and velocity similar to WT in ascl1a / embryos with the addition of 5HT at near physiological
concentrations. Mean value is represented followed by standard deviation. This table shares the WT data with Table 2. A one-way analysis of variance revealed signiﬁcant
differences between the groups; retrograde frequency F(4,1190)¼3.793, p¼0.00, distance F(4,1901)¼87.06, p¼0.00, velocity F(4,1901)¼14.16, p¼0.00; anterograde
frequency F(4,524)¼4.685, p¼0.00, distance F(4,558)¼12.92, p¼0.00, velocity F(4,558)¼78.72, p¼0.00. In post-hoc tests, ascl1a / or ascl1a / with 5HT were
compared to WT to determine either equal or unequal variances using the Fisher test and the appropriate T test was utilized (for equal of unequal variances). Values that
differ signiﬁcantly after Bonferroni correction (po0.01). from WT are indicated in bold with p value from T test.
Retrograde Frequency Distance Velocity
WT 2.871.6 174.6758.2 9.274
ascl1a / 2.871.3 170.7760.3 10.475.3 (P¼3.7104)
ascl1a / 5HT 2.971.7 172.6761.7 9.274.7
Anterograde Frequency Distance Velocity
WT 1.671.5 371.8758 11.572.7
ascl1a / 0.0570.16 (P¼1.11020) 335.8734.2 37.177.4 (P¼6.1103)
ascl1a / 5HT 1.973.2 318.1756.1 (P¼2.51010) 12.074.0
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have the same migration pattern at 74 hpf and appear to have
similar numbers of enteric precursors (compare Fig. 9A and B).
ascl1a / embryos can be distinguished phenotypically at
4 dpf with a smaller but similar enlargement of the proximal
intestine than observed at 5 dpf (Fig. 2B). We ﬁnd that phox2B
expression is lost within ascl1a / embryos (Fig. 9C compared to
Fig. 9D), suggesting that enteric neural precursors have been lost
by this stage. Staining with acridine orange at 96 hpf demonstrates
no observable cell death within either wild type or ascl1a /
intestines, suggesting that enteric precursors have already under-
gone apoptosis at this point. This would indicate that enteric
neural precursors enter the intestine and migrate to the correct
position by 74 hpf, but the majority fail to undergo differentiation
in ascl1a / embryos. Enteric neural precursors may require
products from secretory cells for proper differentiation.
Subtypes of enteroendocrine cells secrete products that are also
able to alter intestinal motility by acting on mucosal enteric neurons
and surrounding tissue (Gunawardene et al., 2011; Hansen and
Witte, 2008; Mawe et al., 2006; Spiller, 2011). Due to the loss of all
secretory cells in ascl1a / embryos we investigated whether
there were alterations in intestinal motility. Motility within the
intestine was analyzed using volumetry to generate spatiotemporal
maps for determining frequency, velocity, distance, interval, and
direction of intestinal contractions. As shown previously, sponta-
neous intestinal contractions originate at a point just distal to the
end of the swim bladder (Holmberg et al., 2007; Kuhlman and Eisen,
2007). From this origin, one contraction proceeds retrograde and the
other anterograde (Fig. 10A). The retrograde contraction travels
through the intestinal bulb and appears to be involved primarily in
mixing. The anterograde contraction travels to the end of the
intestine and appears to be similar to the mammalian migrating
motor complex (MMC), which is involved in propulsion of luminal
contents to the anus. Both of these contractions are spontaneous, as
the embryos have not yet been fed. As demonstrated in Table 1 (and
Supplemental Fig. 1), WT 5 dpf embryos have regular retrograde and
anterograde contractions that consistently travel the entire distance
of these regions. Retrograde contractions occur more frequently
than anterograde contractions but travel at similar velocities.
In ascl1a / 5 dpf embryos, retrograde contractions are pre-
sent with a similar frequency, distance, and velocity to WT
embryos (Fig. 10D and Table 1). In contrast, there is a complete
absence of anterograde contractions. Instead of contractions, nearly
the entire distal lumen will infrequently increase in diameter (fourevents occur in the entire group of n¼10 compared to 10–12 per
WT embryo), which appears to be a way of venting what appears
to be increased proximal pressure due to the remaining retrograde
contractions (Table 1 and Supplemental Fig. 2). This enlargement of
the intestinal diameter does not appear to involve smooth muscle
contraction. Loss of anterograde motility could be due to non-
functional smooth muscle, reduction of enteric neurons, or loss of
secretory cells in the intestinal epithelium.5HT initiates distal intestinal motility in ascl1a / 5 dpf
embryos
In both embryonic and adult intestines enteroendocrine cells
receive and interpret information from the lumen and relay the
information to enteric neurons and surrounding tissue. Entero-
chromafﬁn cells (EC) produce and release serotonin (5HT) upon
interaction with luminal chemicals or stretch (Spiller, 2011) and
alter motility upon binding a variety of 5HT receptors (Gershon
and Tack, 2007; Hansen, 2003; Hansen and Witte, 2008; Mawe
et al., 2006). Within the zebraﬁsh intestine, EC cells are present
only within the distal intestine and correspond to the region that
lacks motility. While ascl1a / 5 dpf embryos lack all secretory
cells, loss of EC cells may play a critical role in distal motility. We
previously demonstrated that the 5HT concentration can be
quantiﬁed in live embryos using the electrochemical method of
differential pulse voltammetry (DPV) with chitosan modiﬁed
microelectrodes implanted in the distal portion of the intestine
(Ozel et al., 2011). DPV entails insertion of the carbon ﬁber probe
into the intestine, which may lyse some EC cells thereby releasing
5HT. However, as EC cells are not densely packed, probe insertion
is not likely to consistently lyse many EC cells suggesting that part
of the 5HT concentration is normally present within the extra-
cellular matrix. This basal 5HT concentration may initiate a
myogenic reﬂex that is absent with loss of 5HT in ascl1a / .
If loss of distal intestinal motility is due to low 5HT concen-
tration, then replacement of 5HT should alter motility in ascl1a /
 5 dpf embryos. ascl1a / embryos were placed in a 300 mM
5HT E3 solution for one hour and then washed out. As demon-
strated previously, DPV recordings before addition of 5HT in
ascl1a / embryos demonstrate an average 5HT concentration
of 2.09 (73.27) nM (n¼9), estimated using a calibration curve.
Variation in 5HT concentration is likely due to the variability of
inserting the probe near one of the remaining 5HT containing
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incubated in 5HT, voltammetric responses record an average
concentration of 5HT of 55.15 (710.9) nM (n¼9) (WT concentra-
tion is 30.8 (73.4) nM (n¼3).
Increased 5HT tissue concentration in ascl1a / embryos
results in anterograde contractions in addition to the retrograde
contractions (Fig. 10F) that are not signiﬁcantly different than WT
values for distance, velocity, and frequency (Table 1 and Supple-
mental Fig. 3). The standard deviation in the frequency measure-
ment is high due to increased variability of the number of
anterograde contractions per embryo. However, the distance
and velocity of anterograde contractions show similar variability
to WT values. Anterograde contractions are initiated at the same
location as WT embryos, just distal to the end of the swim
bladder, and proceed to the anus. Within the proximal intestine,
there is no signiﬁcant change in frequency, velocity or distance of
retrograde contractions. This suggests that smooth muscle is
functional and 5HT receptors are present which alter motility in
the distal intestine. In contrast, no distal contractions develop
when ascl1a / embryos are soaked in a solution without 5HT.Fig. 11. Model for formation of intestinal epithelial secretory cells and require-
ment for motility. (A) We ﬁnd that ascl1a expression is a critical step in
speciﬁcation of secretory cells. Loss of secretory cells results in loss of distal but
not proximal intestinal motility. We ﬁnd Notch signaling is active at two points in
speciﬁcation of intestinal epithelial cells as either secretory or enterocytes. (B) In
this model, we propose that Notch signaling between 30 and 34 hpf is involved in
the potentiation of intestinal epithelial cells to become either secretory cells or
enterocytes via lateral induction. (C) Later, ascl1a is expressed in cells with
secretory potential, inducing deltaD to activate Notch signaling in surrounding
cells. We propose that this stage involves classical lateral inhibition to restrict the
number of secretory cells.Pharmacological alteration of 5HT does not mimic loss of distal
motility in ascl1a /
Increased 5HT concentration results in wild type values of
anterograde motility in ascl1a / embryos (except for a decrease
in distance traveled by the contraction) suggesting that EC cells are
able to initiate and drive anterograde motility. However, all of the
other enteroendocrine products are also absent. To determine
whether loss of 5HT is the sole factor for initiation and main-
tenance of anterograde motility, we pharmacologically manipu-
lated 5HT in WT embryos and recorded their intestinal motility to
determine if there are changes in frequency, velocity, or distance.
We recently demonstrated that application of reserpine, which
blocks the vesicular monoamine transporter, lowers the concen-
tration of 5HT to undetectable levels within the live zebraﬁsh
intestine using DPV (Njagi et al., 2010). In contrast, ﬂuvoxamine, a
serotonin reuptake inhibitor (SSRI), doubles the WT concentration
of 5HT within the intestine (Njagi et al., 2010).
While there are some signiﬁcant changes when 5HT is removed,
we do not observe the loss of the anterograde motility seen in
ascl1a / . We do observe changes in retrograde contractions,
which suggests that altering 5HT concentrations can modify this
motility (Table 2), but not alter it far from WT values. Therefore,
the products of other secretory cells are likely to produceTable 2
Changes in 5 dpf intestinal motility with pharmacological modulation of 5HT concentr
vesicular monoamine transporter and lowers 5HT concentration to undetectable levels,
concentration of 5HT. These embryos were then analyzed by volumetry for frequency
group). The distance of anterograde intestinal contractions are altered by loss of 5HT
retrograde contractions demonstrate signiﬁcant changes. The concentration of 5HT is d
one-way analysis of variance revealed signiﬁcant differences between the groups wi
compared to WT to determine either equal or unequal variances using the Fisher test a








Fluvoxamine 2.1171.7 (P¼5.7103)overlapping or compensatory effects, allowing WT motility even
when one of the signals is removed. Loss of other secretory
products is also required for loss of distal intestinal motility.Discussion
Here we demonstrate that ascl1a is a key transcription factor
in differentiation of zebraﬁsh intestinal secretory cells. Loss of
ascl1a results in complete loss of all intestinal epithelial secretory
cells, which instead differentiate into enterocytes (Fig. 11A). Loss
of ascl1a also results in loss of deltaD expression within the
intestinal epithelium suggesting ascl1a expression is necessary to
initiate and possibly maintain Notch signaling (Fig. 11C). Similar to
mammalian intestinal development, zebraﬁsh also has a common
progenitor for all intestinal epithelial secretory cells that is depen-
dent on a proneural basic helix-loop-helix (bHLH) transcription
factor for initial speciﬁcation.
In mammals, atoh1/math1 is the atonal family member
required to specify secretory cells (Yang et al., 2001). In this
study, we ﬁnd that ascl1a is the ascl family member that speciﬁes
intestinal epithelial secretory cells in zebraﬁsh. While theation. WT 5 dpf embryos were incubated with either reserpine, which blocks the
or ﬂuvoxamine, a serotonin reuptake inhibitor (SSRI) which doubles the intestinal
, (cycles/min), distance (mm), and velocity (mm/s) of contractions (n¼10 for each
in otherwise WT embryos, but not frequency or velocity. Only the distance of
oubled by ﬂuvoxamine. Average value is listed followed by standard deviation. A
th results as listed in Table 1. In post-hoc tests, reserpine or ﬂuvoxamine were
nd the appropriate T test was utilized (for equal of unequal variances). Values that
with P value from T test.
Distance Velocity
174.6758.2 9.274
191.0757 (P¼2.4105) 8.573.4 (P¼6.3103)
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atonal family members have only 45% homology while ascl
members have 70% homology (Bertrand et al., 2002). The ascl
and atoh families of transcription factors share conserved function
across invertebrates to vertebrates (Bertrand et al., 2002). ascl and
atonal family members have conserved expression domains and
functions between zebraﬁsh and mammals (Cau and Wilson,
2003; Lucas et al., 2006; Madelaine and Blader, 2011; Mueller
and Wullimann, 2003; Wullimann and Mueller, 2002, 2004).
Between zebraﬁsh and mammals, ascl and atoh appear to have
switched roles in intestinal epithelial secretory cell speciﬁcation
while retaining homologous roles in other tissues.
Role of Notch signaling and ascl1a in epithelial development during
mid-embryogenesis
In this study, we ﬁnd that Notch signaling is active in intestinal
epithelial development during 64–74 hpf. DAPT inhibition of
gamma secretase during this period demonstrates statistically
signiﬁcant increases in ascl1a and deltaD expressing cells as well
as the pan-secretory marker 2F11. We ﬁnd that ascl1a intestinal
epithelial expression during this period appears to be involved in
initiation of expression of the Notch ligand, deltaD (Fig. 11C).
Within zebraﬁsh, ascl1a has been shown to be capable of direct
regulation of deltaD and is dependent on a speciﬁc group of E boxes
within the HII control region (Hans and Campos-Ortega, 2002).
Regulation of Delta ligands by ascl1 also occurs in other systems.
ascl1 is required for delta expression within the mouse and chicken
retinal progenitors as well as formation of mouse spinal sensory
interneurons (Mizuguchi et al., 2006; Nelson et al., 2009).
ascl1a expression combined with initiation of deltaD suggests
Notch signaling is involved in classic lateral inhibition during this
period (Fig. 11C). During the second day of embryogenesis, all of
the intestinal epithelial cells expressing ascl1a would have the
potential to differentiate into secretory cells. Up-regulation of
ascl1a in one or more cells would then increase deltaD expression.
Increased DeltaD levels would initiate Notch signaling in sur-
rounding cells to specify enterocytes. Initially, there would be a
larger group of intestinal epithelial cells with the potential to
become secretory cells. Notch signaling would, therefore, restrict
the number of secretory cells to a few in each group. In this
scenario, lack of Notch signaling would cause all of the ascl1a
expressing epithelial cells to differentiate into secretory cells.
Role of Notch signaling during early epithelial development
We also observe Notch signaling within the intestinal epithe-
lium between 30 and 34 hpf. DAPT inhibition of gamma secretase
during this period causes statistically signiﬁcant increases in
ascl1a and deltaD expressing cells as well as increases in cells
expressing the pan-secretory cell marker 2F11. ascl1a is required
for secretory cell speciﬁcation; however, this is ten hours before
expression of ascl1a is ﬁrst detected within the intestinal epithe-
lium at 44 hpf. We suggest then that Notch signaling during this
period is instead involved in the formation of pro-secretory
domains within the intestinal epithelium that later have the
potential to become secretory when ascl1a is expressed.
Previously, in the Notch signaling defective mutant mindbomb
(mib), all epithelial cells appear to become secretory cells as the
entire epithelium expresses 2F11 (Crosnier et al., 2005). If the
secretory fate is the default state, Notch signaling between 30 and
34 hpf might then specify pro-enterocyte domains which would
not express ascl1a later during the second day of embryogenesis
(Fig. 11B). Inhibition of Notch signaling during this period would
allow the entire epithelium to form as a pro-secretory domain. If
the entire epithelium becomes a pro-secretory domain, manyadditional secretory cells will begin differentiating. Notch signal-
ing through lateral inhibition would still be able to specify
enterocytes between 64 and 74 hpf.
Between 30 and 34 hpf the intestinal epithelium has just
begun to form a tube with six to seven cells lining the proximal
lumen and only three to four in the distal lumen (Wallace and
Pack, 2003). Therefore whether Notch signaling is specifying a
secretory or enterocyte fate during this stage, the epithelial cells
that receive Notch signaling will need to maintain their speciﬁca-
tion as they proliferate since this period of Notch signaling occurs
within a short four hour window.Alteration of secretory cells during continuous Notch inhibition
Inhibition of Notch signaling produces increased numbers of
secretory cells at mid-embryogenesis. Increased secretory cell
numbers should also be observed at the end of embryogenesis.
However, embryos inhibited for the previous 4–8 h period and
grown to 5 dpf revealed no signiﬁcant change in the number of
secretory cells. Normal numbers of secretory cells at 5 dpf might
be due to compensatory mechanisms or incomplete Notch inhibi-
tion. We hypothesized that continuous inhibition of Notch signal-
ing until the end of embryogenesis might maintain increases in
secretory cell numbers. Embryos inhibited continuously after the
initial exposure to DAPT resulted in nearly the same number of
secretory cells as the WT control exposed to DMSO as observed
with the pan-secretory cell marker, 2F11.
We suggest that DAPT may not provide enough continuous Notch
inhibition over the course of embryogenesis to signiﬁcantly alter the
total number of secretory cells. A similar lack of complete Notch
signaling after DAPT treatment was observed during lateral line
formation (Matsuda and Chitnis, 2010). In these experiments, loss
of all Notch signaling due to Delta ligand in the mindbomb (mib)
mutant removes expression of the Notch target gene, her4. Exposure
to DAPT or morpholino knockdown of notch3 combined with a
notch1amutant does not result in loss of her4 expression. In contrast,
DAPT exposure combined with notch3 morpholino and notch1a
mutant does result in loss of her4 expression similar to the mib
phenotype. This suggests that even low levels of Notch signaling are
able to induce target gene expression albeit at what may be a lower
level. Lower levels of Notch signaling, however, may be enough to
cause signiﬁcant changes in the numbers of various subtypes of
secretory cells. We observe a signiﬁcant increase in enterochromafﬁn
cells when Notch inhibition begins at 30 hpf. In contrast, there is a
signiﬁcant decrease in goblet cell numbers when Notch inhibition
begins at 34 hpf with a subsequent increase beginning at 60 hpf.
Alterations in numbers of secretory cell subtypes could be due
to differential effects of Notch inhibition as there are four
different Notch receptors in zebraﬁsh. Each of the receptors might
also perform different time dependent tasks or only act on certain
secretory cell subtypes. Within the embryonic zebraﬁsh intestine,
previously identiﬁed secretory cells, such as goblet and pancreatic
polypeptide cells, develop within speciﬁc proximal or distal
boundaries (Njagi et al., 2010; Wallace et al., 2005a). We ﬁnd
that wild type boundaries between proximal and distal secretory
cell domains are maintained even with Notch signaling inhibition.
Notch receptors limited to proximal or distal domains would then
be able to differentiate a subset of secretory cells.
While there appears to be a common secretory precursor it is
likely that there are further differentiation steps, creating lineages
that would only differentiate into a subset of secretory cells.
Previously, enterocytes and subtypes of secretory cells have been
observed to begin differentiation at different times during embry-
ogenesis (Ng et al., 2005; Njagi et al., 2010; Wallace et al., 2005a).
The subtypes of secretory precursors may also be affected by
G. Roach et al. / Developmental Biology 376 (2013) 171–186 185Notch signaling and respond differently to Notch inhibition,
further altering numbers of secretory cell subtypes.
Role of secretory cells in intestinal motility
In ascl1amutants, we ﬁnd that loss of all secretory cells within
the intestinal epithelium results in a loss of motility in the distal
intestine. This suggests that products of enteroendocrine cells
play a signiﬁcant role in initiating and driving motility in the
embryonic intestine (Fig. 11A). ascl1a mutants also lose the
majority of enteric neurons. Previously, however, it has been
demonstrated that enteric neurons do not exert signiﬁcant con-
trol over frequency, velocity, and distance of contractions during
embryogenesis (Holmberg et al., 2007). In addition, extrinsic
innervation remains intact in ascl1a / embryos, which may
provide some neural regulation. Within mammals, serotonin
(5HT) producing secretory cells (enterochromafﬁn cells—EC) play
a critical role in intestinal motility. EC cells release 5HT upon
stimulation by touch or stretch and bind receptors on neurons
and surrounding tissue. As a result, EC cells play a role in the
activation of enteric neural reﬂexes involved in both contraction
and luminal secretion (Hansen and Witte, 2008; Heredia et al.,
2009; Mawe et al., 2006; Spiller, 2011). Zebraﬁsh also have a
distal complement of EC cells in combination with 5HT enteric
neuronal subtypes which produce a homogeneous regional con-
centration of 5HT within the intestine as detected with differ-
ential pulse voltammetry (Njagi et al., 2010).
We ﬁnd that increasing 5HT to near physiological levels in
ascl1a mutant embryos initiates the same velocity and frequency
as wild type contractions, but decreases the distance traveled by
anterograde contractions. While neurites from extrinsic neurons
still appear to be present in ascl1a mutants, only one-tenth of the
expected enteric neurons are present. So few intrinsic neurons
suggest incomplete reﬂex circuits are present and 5HT receptors
on smooth muscle instead induce motility upon introduction to
the system.
The mechanism by which 5HT initiates and maintains motility
in ascl1a / embryos is currently unknown. Within the adult
intestine, as discussed above, 5HT is released at speciﬁc points
from ECs in response to stretch or pressure. With exposure of the
entire intestine to 5HT, there are no longer point sources of 5HT
secretion and we may be exposing other intestinal cells that are
not normally exposed to 5HT. Within mammals, affects of 5HT
alteration are complex with low level increases in 5HT concen-
tration increasing propulsive motility while higher concentration
slow motility due to desensitization of receptors (Linden et al.,
2003; Wade et al., 1996). While 5HT concentrations in this work
are higher than physiological levels, we only observe increased
contractility in ascl1a / embryos after a short exposure. Longer
exposure or higher concentrations to 5HT might desensitize
receptors and slow motility. Further work needs to be done to
determine how 5HT is initiating motility in ascl1a / embryos.
While we ﬁnd that 5HT is sufﬁcient to stimulate motility
within the distal intestine, it is not the only substance that drives
WT motility. If 5HT were the sole enteroendocrine product with
the ability to induce motility, then removing 5HT from the WT
intestine should reduce or remove contractions completely. After
removal of 5HT at 5 dpf with the vesicular monoamine transport
blocker reserpine, we observed only a moderate decrease in
distance that the anterograde contraction travels. We suggest
that distal contractions can be initiated and modulated by 5HT,
but as in mammalian systems other enteroendocrine cell pro-
ducts are also involved in motility.
ascl1a mutants lose anterograde contractions; however, retro-
grade contractions continue with similar frequency, velocity, and
distance. In the 5 dpf intestine, there is a region just distal to theswim bladder which originates both the anterograde and retro-
grade contractions. In ascl1a mutants, this region continues to
contract in a similar manner to WT embryos but only propagates
retrograde contractions. The anterograde contraction appears to
begin but does not continue from this region. The position where
these contractions originate may be a segment that is able to initiate
contractile activity independently of enteroendocrine products or
enteric neurons. There still could be a contribution from extrinsic
innervation. Combination of this segment and the resulting retro-
grade contractions may be part of an endogenous pacemaker
activity that can be modiﬁed by enteroendocrine products and
enteric and extrinsic neurons. Future work will be needed to
determine the role of this region in initiating motility within the
intestine.
In conclusion, ascl1a plays a role in differentiation of a
common secretory cell progenitor within the zebraﬁsh intestinal
epithelium. Loss of ascl1a function results in loss of all intestinal
epithelial secretory cells and loss of distal but not proximal
motility. 5HT initiates motility in the distal intestine but is not
the sole enteroendocrine product to induce contractility. Addi-
tionally, electrochemistry on zebraﬁsh embryos provides a unique
opportunity to rapidly determine quantitative changes in physio-
logical concentrations of many of these products in the live
embryo. The relative ease with which motility can be measured
and altered with compounds added to the media provide an
interesting vertebrate system to investigate the role of enteroen-
docrine cells in intestinal motility.Acknowledgements
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